ASSERTIO THERAPEUTICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ASSERTIO THERAPEUTICS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$217.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-03-10
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$192.63M.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was $3.33M, a 93.10% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$13.61M.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$14.30M, a 142.28% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$217.20M, a 688.49% decline from fiscal 2018.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was $36.91M.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$102.50M.
- ASSERTIO THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$88.72M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$192.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$189.29M derived: sum of 2 quarters · filed 2020-03-10 | -$202.90M derived: sum of 3 quarters · filed 2020-03-10 | -$217.20M 10-K · filed 2020-03-10 |
| 2019-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$10.27M derived: sum of 2 quarters · filed 2019-11-07 | -$24.57M 10-Q · filed 2019-11-07 | -$48.71M derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-06-30 | -$13.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$27.91M 10-Q · filed 2019-08-09 | -$52.04M derived: sum of 3 quarters · filed 2020-03-10 | -$3.77M derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-03-31 | -$14.30M 10-Q · filed 2019-05-09 | -$38.44M derived: sum of 2 quarters · filed 2020-03-10 | $9.83M derived: sum of 3 quarters · filed 2020-03-10 | -$11.22M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-12-31 | -$24.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $24.13M derived: sum of 2 quarters · filed 2020-03-10 | $3.08M derived: sum of 3 quarters · filed 2020-03-10 | $36.91M 10-K · filed 2020-03-10 |
| 2018-09-30 | $48.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $27.22M derived: sum of 2 quarters · filed 2019-11-07 | $61.05M 10-Q · filed 2019-11-07 | $27.94M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$21.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $12.78M 10-Q · filed 2019-08-09 | -$20.33M derived: sum of 3 quarters · filed 2020-03-10 | -$36.32M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | $33.82M 10-Q · filed 2019-05-09 | $720.00K derived: sum of 2 quarters · filed 2020-03-10 | -$15.27M derived: sum of 3 quarters · filed 2020-03-10 | -$41.93M derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$33.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$49.10M derived: sum of 2 quarters · filed 2020-03-10 | -$75.75M derived: sum of 3 quarters · filed 2020-03-10 | -$102.50M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$15.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$42.65M derived: sum of 2 quarters · filed 2018-11-09 | -$69.39M 10-Q · filed 2018-11-09 | -$113.76M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | -$26.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$53.40M 10-Q · filed 2018-08-08 | -$97.77M derived: sum of 3 quarters · filed 2019-03-11 | |
| 2017-03-31 | -$26.74M 10-Q · filed 2018-05-10 | -$71.11M derived: sum of 2 quarters · filed 2019-03-11 | ||
| 2016-12-31 | -$44.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$88.72M 10-K · filed 2019-03-11 | ||
| 2016-09-30 | -$44.35M 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | -$75.74M 10-K · filed 2018-03-01 | |||
| 2011-12-31 | $70.64M 10-K · filed 2012-03-08 | |||
| 2010-12-31 | $3.93M 10-K · filed 2012-03-08 | |||
| 2009-12-31 | -$22.13M 10-K · filed 2012-03-08 |